Susan Gerber to Cost-Benefit Analysis
This is a "connection" page, showing publications Susan Gerber has written about Cost-Benefit Analysis.
Connection Strength
0.084
-
Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines. Clin Infect Dis. 2017 Sep 15; 65(6):1020-1025.
Score: 0.084